[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364975-105":59,"doc-detail-364975-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cytokeratin-17-activates-akt-signaling-to-induce-epithelial-mesenchymal-transition-and-promote-bladder-cancer-progression","Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression","","Bladder cancer is a prevalent urinary tract malignancy and a major global cancer burden. This study investigates how cytokeratin 17 (CK17) drives epithelial-mesenchymal transition (EMT) and accelerates bladder cancer progression, focusing on the biological and clinical significance of CK17 expression. In 78 tissue specimens, CK17 levels were assessed by immunohistochemistry, correlated with patient prognosis, and experimentally evaluated in CK17-silenced or overexpressing cell models using proliferation, migration, invasion, and AKT/EMT marker analyses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cytokeratin-17-activates-akt-signaling-to-induce-epithelial-mesenchymal-transition-and-promote-bladder-cancer-progression/364975/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cytokeratin-17-activates-akt-signaling-to-induce-epithelial-mesenchymal-transition-and-promote-bladder-cancer-progression/364975.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study on CK17 in bladder cancer?","Question",{"text":112,"@type":113},"To investigate the mechanism by which cytokeratin 17 induces epithelial-mesenchymal transition and promotes bladder cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CK17 expression measured and linked to clinical outcomes?",{"text":117,"@type":113},"CK17 levels in 78 bladder cancer and paracancerous tissue specimens were detected by immunohistochemistry and analyzed against prognosis using follow-up visits.",{"name":119,"@type":110,"acceptedAnswer":120},"What signaling pathway and EMT markers are associated with CK17 effects?",{"text":121,"@type":113},"CK17 overexpression activates AKT signaling via phosphorylation of AKT (Ser473), and alters EMT-related mesenchymal markers and EMT-associated transcription factors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364975,1790179387,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Zhang et al. BMC Urology (2025) 25:77 [https://doi.org/10.1186/s12894-025-01760-4](https://doi.org/10.1186/s12894-025-01760-4)  \nBMC Urology  \nRESEARCH Open Access  \nCytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression  \nPei Zhang 1†, Mingkai Liu2†, Shun Zhang 1, Cuijuan Lu 1, Qianhe Zu3, Yuemian Liang 1, Zhenyu Cui2, Jialin Liu 1, Yanan Wang 1* and Chunyan Bu4*  \nAbstract  \nObjective Bladder cancer is a common malignant tumor of the urinary tract as well as one of the most common cancers worldwide. Therefore, the study of key molecular targets involved in bladder carcinogenesis and progression is crucial for the prognosis of bladder cancer. Our study aims to investigate the mechanism by which cytokeratin 17 induces epithelial-mesenchymal transition and promotes bladder cancer progression.  \nMethods In this study, 78 bladder cancer tissue specimens were collected, the expression level of cytokeratin 17 (CK17) in bladder cancer and paracancerous tissues was detected by immunohistochemistry, and the relationship between the CK17 expression level and the prognosis of the patients was analyzed via follow-up visits. Western Blot was performed to detect the expression level of CK17 in common bladder cancer cell lines, and the CK17-silenced and overexpressed cell lines were constructed from the selected T24 cell line with high expression of CK17 and 5637 cell line with low expression of CK17 . The effects of CK17 on the proliferation, migration and invasion abilities of bladder cancer cells were evaluated by flow cytometry, Cell Counting Kit-8 (CCK-8) assay, Trans-well assay, and scratch assay. The effect of CK17 on epithelial-mesenchymal transition (EMT) markers was further detected by Western Blot and immunofluorescence, and the phosphorylation level s ofAKT Ser473 and Thr308 were detected by Western Blot. Results In the clinical samples, CK17 expression was significantly up-regulated in cancer tissues compared with paracancerous tissues, and high levels of CK17 indicated shortened progression free survival and predicted a poorer clinical prognosis. By analyzing the relationship between CK17 and clinicopathological features, we found that the CK17 expression level was correlated with bladder cancer grade and TNM stage. Overexpression of CK17 promoted the proliferation, migration and invasion abilities of bladder cancer cells 5637, and silencing of CK17 inhibited the proliferation, migration and invasion abilities of bladder cancer cells T24 . Further, we found that overexpression of CK17 in 5637 cells activated the AKT signaling pathway by increasing the phosphorylation level of AKT (Ser473), so as  \n†Pei Zhang and Mingkai Liu contributed equally to this work.  \n*Correspondence: Yanan Wang[wyn781202@163.com](wyn781202@163.com)[ ](wyn781202@163.com)Chunyan Bu [BU3342060@163.com](BU3342060@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](htt","cbCaidoLQAgKuAfG","https://ap.wps.com/l/cbCaidoLQAgKuAfG","pdf",2228190,12,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main objective of the study on CK17 in bladder cancer?\",\"answer\":\"To investigate the mechanism by which cytokeratin 17 induces epithelial-mesenchymal transition and promotes bladder cancer progression.\"},{\"question\":\"How was CK17 expression measured and linked to clinical outcomes?\",\"answer\":\"CK17 levels in 78 bladder cancer and paracancerous tissue specimens were detected by immunohistochemistry and analyzed against prognosis using follow-up visits.\"},{\"question\":\"What signaling pathway and EMT markers are associated with CK17 effects?\",\"answer\":\"CK17 overexpression activates AKT signaling via phosphorylation of AKT (Ser473), and alters EMT-related mesenchymal markers and EMT-associated transcription factors.\"}]","Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression | PDF",1790159590,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f11f3c1a1aa484abab7bb75a7f661e84.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd5bfd097346b0af97a25f29ac9d5205.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f7c1ae9cc1a1c41cb3f06488ecd3449.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66107dd14a6621be9390ec613bd2bc1d.webp",980,1306]